Home > Products > CD28 & EGFR
> Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Fab-VHH-Fc)
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Fab-VHH-Fc) (CAT#: FABVC-367)
Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Fab-VHH-Fc) requires expression of three polypeptide chains, encoding two heavy chains (Fc-containing chains) and one light chain, respectively. The Fab of anti-CD28 antibody variable domain is fused to the Fc-knob domain with a hinge region and the same as the VHH of anti-EGFR to the Fc-hole domain, or vice versa. The Fab-Fc and VHH-Fc fragments can be paired via the interaction of the Fc regions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Fab-VHH-Fc) (FABVC-367). Click the button below to contact us or submit your feedback about this product.